xanthenes has been researched along with Colorectal Cancer in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Y; Gu, Y; Li, Y; Lu, Y; Wang, H; Wu, M | 1 |
| Bi, Y; Guo, J; Liu, Y; Pan, L; Tan, Y; Yu, X; Zhao, Q; Zhong, J | 1 |
| Blanchard, C; Chinkwo, K; Johnson, S; Rao, S; Santhakumar, A | 1 |
| Allenby, G; Mallinder, PR; Wallace, AV | 1 |
| Begent, RH; Boden, JA; Boden, R; Boxer, GM; Flynn, AA; Keep, PA; Pedley, RB | 1 |
| Begent, RH; Boden, R; Boxer, GM; Davies, L; Pedley, RB; Sharma, SK; Springer, CJ; Stribbling, SM | 1 |
6 other study(ies) available for xanthenes and Colorectal Cancer
| Article | Year |
|---|---|
Neogambogic acid suppresses characteristics and growth of colorectal cancer stem cells by inhibition of DLK1 and Wnt/β-catenin pathway.
Topics: Apoptosis; beta Catenin; Calcium-Binding Proteins; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Glycogen Synthase Kinase 3 beta; Humans; Membrane Proteins; Neoplastic Stem Cells; Proliferating Cell Nuclear Antigen; Wnt Signaling Pathway; Xanthenes | 2022 |
Gambogenic acid induces Noxa-mediated apoptosis in colorectal cancer through ROS-dependent activation of IRE1α/JNK.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Endoplasmic Reticulum Stress; Endoribonucleases; Female; Humans; JNK Mitogen-Activated Protein Kinases; Mice, Inbred BALB C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Xanthenes; Xenograft Model Antitumor Assays | 2020 |
Apoptosis Induction Pathway in Human Colorectal Cancer Cell Line SW480 Exposed to Cereal Phenolic Extracts.
Topics: Annexins; Apoptosis; Caspases; Cell Line, Tumor; Colorectal Neoplasms; Edible Grain; Humans; Oxazines; Phenols; Plant Extracts; Tumor Suppressor Protein p53; Xanthenes | 2019 |
Identification of iNOS inhibitors using InteraX.
Topics: Animals; beta-Galactosidase; Binding Sites; Biological Assay; Carcinoma; Cell Line; Cell Line, Tumor; Colorectal Neoplasms; Dimerization; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fibroblasts; Humans; Indicators and Reagents; Inhibitory Concentration 50; Kidney; Mice; Models, Biological; Molecular Structure; Nitric Oxide Synthase Type II; Oxazines; Protein Binding; Proteins; Reproducibility of Results; Retroviridae; Transduction, Genetic; Xanthenes | 2009 |
Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agents.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Carcinoembryonic Antigen; Colorectal Neoplasms; Combined Modality Therapy; Flavonoids; Humans; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Radioimmunotherapy; Regional Blood Flow; Serotonin; Tissue Distribution; Transplantation, Heterologous; Xanthenes; Xanthones | 1996 |
Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent.
Topics: Animals; Antineoplastic Agents; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; gamma-Glutamyl Hydrolase; Glutamates; Humans; Immunoconjugates; Immunoglobulin Fab Fragments; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Nitrogen Mustard Compounds; Prodrugs; Transplantation, Heterologous; Xanthenes; Xanthones | 1999 |